Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature

Immune Checkpoint Inhibitor Associated Autoimmune Encephalitis, Rare and Novel Topic of Neuroimmunology: A Case Report and Review of the Literature

Immune checkpoint inhibitors (ICIs) are being used in patients with various advanced malignancies, and patient outcomes have improved considerably. Although ICIs can effectively treat tumors, 30–60% of patients experience immune-related adverse events (irAEs). Autoimmune encephalitis (AE) is a rare...

Full description

Bibliographic Details
Main Authors: Yining Gao, Jie Pan, Dingding Shen, Lisheng Peng, Zhifeng Mao, Chunxia Wang, Huanyu Meng, Qinming Zhou, Sheng Chen
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Brain Sciences
Subjects:
immune checkpoint inhibitors
immune-related adverse event
autoimmune encephalitis
pembrolizumab
Online Access:https://www.mdpi.com/2076-3425/12/6/773

Internet

https://www.mdpi.com/2076-3425/12/6/773

Similar Items